Subtype

Thyroid Gland Medullary Carcinoma

25 active trials3 approved drugs18 evidence items

NCIt: C3879
OncoTree: THME
DOID: 3973
UMLS CUI: C0238462

Clinical trials

Registered studies

105 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 8
Ph III recruiting: 1
Growth YoY: —
Industry share: 32%
Top sponsor: Eli Lilly and Company
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11)

No study matches these filters